If the β-ARs are necessary for the time-dependent restabilization process, the mnemonic output should be intact in the first hours after administering the amnesic drug (β-blocker), while post-reactivation amnesia should only be observed several hours later (experiment 3). The gene discussed is CTBP1; the disease is amnesia.